Skip to main content

Table 1 Baseline patient characteristics before and after propensity score matching

From: Lobectomy versus segmentectomy in patients with stage T (> 2 cm and ≤ 3 cm) N0M0 non-small cell lung cancer: a propensity score matching study

Characteristic

Surgical procedure unmatching

Surgical procedure matching

Total (N = 5783)

Lobectomy (N = 5531)

Segmentectomy (N = 252)

Pb value

Total (N = 755)

Lobectomy (N = 503)

Segmentectomy (N = 252)

P value

Age (years), n (%)

   

0.001

   

0.472

 ≤ 60

1351 (23.4)

1308 (23.6)

43 (17.1)

 

129 (17.1)

86 (17.1)

43 (17.1)

 

 61–70

2011 (34.8)

1928 (34.9)

83 (32.9)

 

238 (31.5)

155 (30.8)

83 (32.9)

 

 71–80

1945 (33.6)

1855 (33.5)

90 (35.7)

 

295 (39.1)

205 (40.8)

90 (35.7)

 

  ≥ 81

476 (8.2)

440 (8.0)

36 (14.3)

 

93 (12.3)

57 (11.3)

36 (14.3)

 

 Mean ± SD

67.47 ± 10.25

67.37 ± 10.24

69.75 ± 10.32

< 0.001

69.67 ± 9.96

69.63 ± 9.78

69.75 ± 10.32

0.880

Sex, n (%)

   

0.743

   

0.316

 Female

3225 (55.8)

3087 (55.8)

138 (54.8)

 

394 (52.2)

256 (50.9)

138 (54.8)

 

 Male

2558 (44.2)

2444 (44.2)

114 (45.2)

 

361 (47.8)

247 (49.1)

114 (45.2)

 

Race, n (%)

   

0.605

   

0.944

 White

4871 (84.2)

4664 (84.3)

207 (82.1)

 

625 (82.8)

418 (83.1)

207 (82.1)

 

 Black

463 (8.0)

439 (7.9)

24 (9.5)

 

70 (9.3)

46 (9.1)

24 (9.5)

 

 Others

449 (7.8)

428 (7.7)

21 (8.3)

 

60 (7.9)

39 (7.8)

21 (8.3)

 

Marital status, n (%)

   

0.397

   

0.859

 Noa

3430 (59.3)

3237 (59.4)

143 (56.7)

 

425 (56.3)

282 (56.1)

143 (56.7)

 

 Yes

2353 (40.7)

2244 (40.6)

109 (43.3)

 

330 (43.7)

221 (43.9)

109 (43.3)

 

Laterality, n (%)

   

0.005

   

0.817

 Left

2418 (41.8)

2291 (41.4)

127 (50.4)

 

376 (49.8)

249 (49.5)

127 (50.4)

 

 Right

3365 (58.2)

3240 (58.6)

125 (49.6)

 

379 (50.2)

254 (50.5)

125 (49.6)

 

Primary Site, n (%)

   

0.063

   

0.659

 Upper

3524 (60.9)

3380 (61.6)

144 (57.1)

 

428 (56.7)

284 (56.5)

144 (57.1)

 

 Middle

305 (5.3)

297 (5.4)

8 (3.2)

 

31 (4.1)

23 (4.6)

8 (3.2)

 

 Lower

1954 (33.8)

1854 (33.5)

100 (39.7)

 

296 (39.2)

196 (39.0)

100 (39.7)

 

Histopathology, n (%)

   

0.111

   

0.290

 ADC

2450 (42.4)

2355 (42.6)

95 (37.7)

 

282 (37.4)

187 (37.2)

95 (37.7)

 

 SCC

1234 (21.3)

1184 (21.4)

50 (19.8)

 

174 (23.0)

124 (24.7)

50 (19.8)

 

 Others

2099 (36.3)

1992 (36.0)

107 (42.5)

 

299 (39.6)

192 (38.2)

107 (42.5)

 

Grade, n (%)

   

0.227

   

0.917

 I

1357 (23.5)

1309 (23.7)

48 (19.0)

 

140 (18.5)

92 (18.3)

48 (19.0)

 

 II

2649 (45.8)

2529 (45.7)

120 (47.6)

 

356 (47.2)

236 (46.9)

120 (47.6)

 

 III–IV

1777 (30.7)

1693 (30.6)

84 (33.4)

 

259 (34.3)

175 (34.8)

84 (33.3)

 

OS, n (%)

   

0.001

   

0.739

 Alive

3754 (64.9)

3616 (65.4)

138 (54.8)

 

407 (53.9)

269 (53.5)

138 (54.8)

 

 Dead

2029 (35.1)

1915 (34.6)

114 (45.2)

 

348 (46.1)

234 (46.5)

114 (45.2)

 

LCSS, n (%)

   

0.020

   

0.755

 Alive

4706 (81.4)

4515 (81.6)

191 (75.8)

 

567 (75.1)

376 (74.8)

191 (75.8)

 

 Dead

1077 (18.6)

1016 (18.4)

61 (24.2)

 

188 (24.9)

127 (25.2)

61 (24.2)

 
  1. ADC, adenocarcinoma; SCC, squamous cell carcinoma; I, well differentiated; II, moderately differentiated; III-IV, poorly differentiated/ undifferentiated; OS, overall survival; LCSS, lung cancer-specific survival; SD, standard deviation
  2. aNo included separated, single (never married), divorced, unmarried or domestic partner and widowed
  3. bP value between lobectomy and segmentectomy was calculated using the chi-square test